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Background: Bacillus anthracis is the etiological agent of anthrax. Lethal toxin (LT) produced by B. anthracis is a
well-known key virulence factor for anthrax because of its strong cytotoxic activity. However, little is known about
the role of B. anthracis genomic DNA (BAG) in anthrax pathogenesis.
Results: We examined the effect of BAG on TNF-α production and LT-mediated cytotoxicity during B. anthracis
spore infection in mouse macrophage cell lines (RAW264.7 cells and J774A.1) and BALB/c mice. Infection of
RAW264.7 cells with B. anthracis spores induced TNF-α expression in a multiplicity of infection (MOI)-dependent
manner, and this enhancement was attenuated by the toll-like receptor (TLR) 9 inhibitor oligodeoxynucleotide
(ODN)2088. BAG led to TNF-α expression in a dose- and time-dependent manner when applied to RAW264.7 cells.
TNF-α expression induced by BAG was reduced by either pretreatment with TLR9 inhibitors (ODN2088 and chloroquine
(CQ)) or transfection with TLR9 siRNA. Furthermore, BAG-induced TNF-α production in TLR9+/+ macrophages was
completely abrogated in TLR9−/− macrophages. BAG enhanced the phosphorylation of mitogen-activated protein
kinases (MAPK), and BAG-induced TNF-α expression was attenuated by pretreatment with MAPK inhibitors. A reporter
gene assay and confocal microscopy demonstrated that BAG increased NF-κB activation, which is responsible for TNF-α
expression. Treatment with BAG alone showed no cytotoxic activity on the macrophage cell line J774A.1, whereas
LT-mediated cytotoxicity was enhanced by treatment with BAG or TNF-α. Enhanced LT-induced lethality was also
confirmed by BAG administration in mice. Furthermore, LT plus BAG-mediated lethality was significantly recovered by
administration of Infliximab, an anti-TNF-α monoclonal antibody.
Conclusions: Our results suggest that B. anthracis DNA may contribute to anthrax pathogenesis by enhancing LT
activity via TLR9-mediated TNF-α production.
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Bacillus anthracis is a Gram-positive, spore-forming bac-
terium that causes anthrax [1]. Intentional use of anthrax
spores as a weapon of bioterror in 2001 has provoked a
need for research to find effective countermeasures [1].
When anthrax spores enter the host via diverse infection
routes, macrophages, major sentinels of the immune* Correspondence: gerhie@nih.go.kr
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unless otherwise stated.system, serve as a reservoir of anthrax spores for germi-
nation. Macrophages then transport the bacteria to re-
gional lymph nodes where the released bacilli multiply
extensively [1,2]. Once vegetative bacilli form, they secrete
high levels of exotoxins and spread systemically via the
bloodstream. The exotoxins are composed of three dis-
tinct proteins, protective antigen (PA), edema factor, and
lethal factor (LF), which are secreted separately as non-
toxic monomers [3]. The binding of LF or edema factor to
PA oligomer results in the formation of active lethal toxin
(LT) or edema toxin, respectively, both of which cause
massive edema, organ failure, and death of the host [1,3].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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http://www.biomedcentral.com/1471-2180/14/300Once the pathogen invades the host, the innate im-
mune response is the first line of defense. Innate im-
mune cells such as macrophages and dendritic cells
elicit inflammatory responses to counteract microbial
infections through pattern-recognition receptors (PRR)
that recognize conserved microbial structures known
as pathogen-associated molecular patterns (PAMP) [4].
The best-characterized family of PRR is the TLRs, which
are evolutionarily conserved from insects to humans [5].
It is well established that each TLR recognizes different
sets of PAMP in bacteria or viruses. Among the PAMP
that have been identified, microbial DNA shows potent
immunomodulating effects on immune cells including
macrophages [6]. This stimulatory effect is due to a high
frequency of unmethylated CpG sequences as compared
with mammalian DNA [7]. Unmethylated microbial
CpG DNA from bacteria, viruses, and fungi is recog-
nized by TLR9, which is expressed in the endosomal
compartment [7]. The engagement of TLR9 subse-
quently recruits MyD88, which is a common adaptor
molecule in TLR-mediated signaling except TLR3 [8].
The interaction of TLR9 with MyD88 in turn activates
IL-1 receptor–associated kinase-4 and −1 and TNF-
associated factor 6, leading to the activation of MAPKs
and NF-κB to produce proinflammatory cytokines such
as TNF-α and IL-6 [9].
Macrophages have been crucially implicated in B.
anthracis–mediated pathogenesis. Once the host is in-
fected, B. anthracis spores are engulfed by macrophages
and induce production of TNF-α and IL-6 [10]. Some
components of the vegetative form of B. anthracis have
also been reported to be recognized by macrophages
and stimulate innate immune responses [11-13]. It was
previously reported that anthrolysin O, a cholesterol-
dependent cytolysin in B. anthracis, induces TNF-α
production in bone marrow–derived macrophages
(BMDM) in a TLR4-dependent manner [13]. In addi-
tion, poly-γ-D-glutamic acid (PGA) capsules in B.
anthracis elicit IL-1β production in PMA-differentiated
THP-1 macrophages [11]. Furthermore, B. anthracis
peptidoglycan (PGN), which is a major component of
bacterial cell walls, stimulates TNF-α production by
human monocytes [12]. Bacterial components such as
PGN, LPS, and PGA sensitize LT-resistant macrophages
to lethal toxin through production of TNF-α [14].
However, the role of other molecules produced by
B. anthracis in innate immunity and pathogenesis re-
mains unclear.
In this study, we investigated the effect of highly puri-
fied BAG on TNF-α production. Furthermore, we exa-
mined the role of BAG on LT-mediated cytotoxicity of
macrophages in vitro and in BALB/c mice. Our results
might suggest the importance of BAG in anthrax
pathogenesis.Results
Infection with B. anthracis spores enhances TLR9 mRNA
and TNF-α expression
To examine whether infection of macrophages with B.
anthracis spores increases TLR9 mRNA expression, we
infected RAW264.7 cells with B. anthracis spores (MOI
of 10) for various time periods and then examined TLR9
mRNA expression using real-time RT-PCR (Figure 1A).
TLR9 mRNA expression significantly increased, peaked
at 6 h and decreased thereafter at 8 h (Figure 1A).
The proinflammatory cytokine TNF-α increases upon
TLR9 activation [15] and plays an important role in
B. anthracis LT-induced cytotoxicity of macrophages
[14,16]. Therefore, we next investigated whether infec-
tion with B. anthracis spores induced the expression of
TNF-α. B. anthracis spores significantly increased the
level of both TNF-α protein and mRNA at a MOI-
dependent manner (Figure 1B). Because TLR9 mRNA
expression was significantly enhanced by B. anthracis
spore infection, we examined whether TLR9 is involved in
B. anthracis spore–induced TNF-α production. B. anthra-
cis spore-induced TNF-α production was attenuated by
the addition of 5 or 10 μM ODN2088, a TLR9 inhibitor, in
a dose-dependent manner to 71.02% (P = 0.031) and
63.05% (P = 0.019), respectively, as compared with that of
samples infected with B. anthracis spores only (Figure 1C).
These results suggest that B. anthracis spores can induce
TNF-α production in macrophages and that TLR9 is
involved in TNF-α production following B. anthracis
spore infection.
BAG induces TNF-α protein and mRNA expression in a
dose- and time-dependent manner
Because B. anthracis spores significantly enhanced TLR9
and TNF-α expression in macrophages, we next examined
whether BAG, which is known to be a TLR9 agonist [6],
induced TNF-α expression at the protein and mRNA
levels using ELISA and real-time RT-PCR, respectively.
BAG significantly augmented the level of both TNF-α pro-
tein and mRNA at a dose-dependent fashion (Figure 2A).
In time-course experiments, BAG-induced TNF-α mRNA
expression increased, peaked at 6 h and declined there-
after up to 24 h. In addition, the level of TNF-α protein
also increased in a time-dependent manner (Figure 2B).
These results showed that BAG induced TNF-α expres-
sion at both the mRNA and protein levels.
BAG stimulates TNF-α production in a TLR9-dependent
manner
Bacterial genomic DNA containing unmethylated CpG
motifs and synthetic CpG ODN both have potent immu-
nostimulating effects including inducing the production
of proinflammatory cytokines in various cell types such
as B cells, macrophages, and dendritic cells through
Figure 1 B. anthracis spore infection enhances TLR9 and
TNF-α expression in RAW264.7 cells. (A) Cells were infected with
B. anthracis spores (MOI of 10) prepared from B. anthracis strain
ATCC 14578 for the indicated times. At the end of the infection
periods, total RNA was prepared, and TLR9 expression was analyzed
using real-time RT-PCR. (B) RAW264.7 cells were infected with increasing
numbers of B. anthracis spores (MOI of 1, 3, 10, or 30). TNF-α protein
(bars) was analyzed by ELISA 8 h after infection; TNF-α mRNA (line)
expression was analyzed by real-time RT-PCR 2 h after infection.
(C) Cells were pretreated with ODN2088 for 1 h and then infected with
B. anthracis spores (MOI of 10) for a further 5 h. At the end of the
incubation period, culture supernatants were collected and subjected to
ELISA. *P <0.05 as compared with the untreated control group (−).
Figure 2 BAG augments TNF-α protein and mRNA expression
in a dose- and time-dependent manner. RAW264.7 cells were
stimulated (A) with various doses of BAG (0, 0.1, 1, or 10 μg/ml) for
24 h (grey bars, for protein level) or 3 h (line, for mRNA level), or
(B) with 10 μg/ml BAG for 0, 3, 6, 12, or 24 h. At the end of the
stimulation, total RNA was extracted or culture supernatants were
collected. Real-time RT-PCR and ELISA were conducted to analyze
BAG-induced TNF-α mRNA and protein levels, respectively. Values
are the mean ± SD of three replicates per group. *P <0.05 as
compared with the untreated control group.
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maturation are required for full activation of TLR9 sig-
naling pathways [7]. Therefore, we examined whether
BAG-induced TNF-α production is mediated through
TLR9. Both the TLR9 inhibitor ODN2088 and the endo-
somal acidification inhibitor CQ significantly attenuated
BAG-induced TNF-α production in a dose-dependent
manner (Figure 3A).To verify that TLR9 is responsible for BAG-induced
TNF-α production, we carried out TLR9 siRNA expe-
riments. TLR9 siRNA significantly reduced the BAG-
and CpG-ODN–induced TNF-α production to 45.2%
(P = 0.0032) and 57.2% (P = 0.0004), respectively, as com-
pared with results from BAG or CpG-ODN treatment in
the presence of the control siRNA (Figure 3B). Addition-
ally, to confirm the involvement of TLR9 on BAG-induced
TNF-α production, we used BMDM from TLR9 WT and
KO mice. BAG-induced TNF-α production was com-
pletely abolished in TLR9 KO BMDM as CpG ODN2395
but not a TLR2 ligand, PAM3CSK4 (Figure 3C, D). To
further verify the role of TLR9 on B. anthracis spores-
induced TNF-α production, we infected BMDM from
TLR9 WT and KO mice with B. anthracis spores. Spores-
induced TNF-α production from TLR9 WT BMDM was
significantly attenuated in TLR9 KO BMDM (Figure 3E).
The amount of TNF-α produced by spore infection in
BMDM was comparable to those using J774A.1 cells
Figure 3 The effect of BAG on TNF-α production is TLR9 dependent. (A) RAW264.7 cells were pretreated with TLR9 inhibitors: 0, 1, 10, or
100 nM ODN2088 or 0, 0.1, 1, or 10 μM CQ for 1 h, followed by stimulation with 10 μg/ml BAG for an additional 24 h. (B) RAW264.7 cells were
transfected with TLR9 siRNA or control siRNA for 48 h. Then, the cells were stimulated with 1 μM CpG ODN2395 as a positive control or 10 μg
BAG for an additional 24 h. (C) BMDM from TLR9 WT and KO mice were stimulated with 0, 0.1, 1, or 10 μg/ml BAG for 24 h. (D) BMDM from
TLR9 WT and KO mice were stimulated with 1 μM CpG ODN2395 or 0.1 μg/ml PAM3CSK4 for 24 h. (E) BMDM from TLR9 WT and KO mice were
infected with increasing numbers of B. anthracis spores (MOI of 1, 3, or 10) for 8 h. At the end of the incubation period, culture supernatants
were collected and subjected to ELISA. *P <0.05 and **P <0.01 as compared with the relevant control group.
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TNF-α production through TLR9-dependent signaling
pathways.
MAPK pathways are essential for BAG-induced TNF-α
production
Because MAPK pathways play a pivotal role in TNF-α
expression [19], we examined whether BAG could in-
duce the phosphorylation of MAPK in RAW264.7 cells
using Western blotting. When the cells were stimulated
with 10 μg/ml BAG for 0, 15, 30, or 60 min, phosphoryl-
ation of MAPK increased beginning at 15 min (ERK or
p38) or 30 min (JNK) after BAG treatment and declined
thereafter (Figure 4A). To further confirm the involve-
ment of MAPK subtypes on BAG-induced TNF-α pro-
duction, cells were pretreated with inhibitors of ERK
(U0126), p38 (SB203580), or JNK kinases (SP600125).
TNF-α production was attenuated by all three MAPKinhibitors in a dose-dependent manner (Figure 4B).
These results indicate that MAPK pathways are critical
for TNF-α production induced by BAG treatment in
RAW264.7 cells.
BAG and B. anthracis spores induce NF-κB activation
The transcription factor NF-κB is important for TNF-α
gene expression [20]. Moreover, NF-κB is regulated by
MAPK during TNF-α expression [21]. Thus, we investi-
gated whether BAG could lead to NF-κB activation using
an NF-κB–driven luciferase reporter system and con-
focal microscopic analysis of NF-κB p65 translocation to
the nucleus. NF-κB luciferase activity was significantly
increased by BAG stimulation in a dose-dependent man-
ner (Figure 5A). Next, we examined whether BAG or
B. anthracis spores could also induce NF-κB activation.
Stimulation of cells with BAG or spore infection remark-
ably increased NF-κB activation, and this was confirmed
p-p38
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Figure 4 MAPK pathways are important for BAG-induced TNF-α
production. (A) RAW264.7 cells were treated with 10 μg/ml BAG for
the indicated time periods. At the end of the stimulation periods,
the cells were lysed, and cell lysates were subjected to western blot
analysis to determine the intracellular levels of ERK, p38, and JNK,
and their phosphorylated forms. (B) RAW264.7 cells were pretreated
with the indicated concentrations of MAPK inhibitors including ERK
(U0126), p38 (SB203580), or JNK (SP600125) for 1 h, followed by
stimulation with 10 μg/ml BAG for an additional 24 h. Values are the
mean ± SD of triplicate samples. *P <0.05 as compared with the
BAG-treated group.
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anti-p65 immunostaining (Figure 5B). These results showed
that BAG or spore infection induced activation of NF-κB,
which is crucially involved in TNF-α gene expression.
Treatment with BAG or TNF-α enhances the cytotoxic
activity of LT on the macrophage cell line J774A.1
LT is a key factor in anthrax pathogenesis, and consti-
tuents of B. anthracis including anthrolysin O and PGA
augment the activity of LT [11,13]. Therefore, we next
determined the effect of BAG on the cytotoxic activity
of LT on J774A.1 cells. Treatment of cells with 10 μg/ml
BAG alone did not affect the cell viability, whereas 1 or10 μg/ml BAG with LT significantly augmented the fre-
quency of cell death (Figure 6A). When cells were
treated with 10 μg/ml BAG with LT, cell viability was
significantly decreased to 63.4% (P = 0.0038) as com-
pared with samples treated with LT only.
Because TNF-α enhances LT-mediated cell death [14]
and because, in the current study, BAG induced sub-
stantial TNF-α secretion by macrophages, we examined
whether pretreatment with TNF-α affected the cytotoxic
activity of LT on J774A.1 cells. Pretreatment with 0.25,
0.5 or 1 μg/ml TNF-α significantly enhanced the cyto-
toxicity of LT (Figure 6B). Pretreatment with TNF-α
(1 μg/ml) significantly decreased cell viability to 25.5%
(P = 9.06 × 10−7) as compared with LT treatment alone.
In addition, we further examined whether pretreatment
of low concentrations of TNF-α can enhance the cyto-
toxicity of LT. Pretreatment with 7.8, 15.6, or 31.2 ng/ml
TNF-α significantly enhanced the cytotoxic activity of
LT, although cytotoxicity was lower than that of high
concentrations of TNF-α treatment (Additional file 1:
Figure S1A). Because BAG induced maximal TNF-α
production in macrophages at 24 h post-stimulation,
we examined whether pretreatment of BAG can also
augment the cytotoxicity of LT. Pretreatment of BAG
enhanced the cytotoxic activity of LT at concentrations
of 1 μg/ml and 10 μg/ml (Additional file 1: Figure S1B).
These results suggest that BAG plays an important role
in LT-induced macrophage death and that TNF-α secre-
tion induced by BAG may be involved in this cell death.
Genomic DNA is detected during anthrax infection and
enhances LT-mediated lethality in mice
To examine the in vivo relevance of BAG pathogenesis,
6-week-old BALB/c female mice were injected with
5 × LD50 of B. anthracis H9401 or PBS as a control
through the tail vein. After 24 h, circulating BAG from
sera was isolated, and PCR was performed using B.
anthracis 16S rRNA gene-specific primers. In sera from
15 of 16 mice injected with B. anthracis spores, ampli-
fication of 16S rRNA gene-specific fragments was ob-
served, whereas B. anthracis 16S rRNA was not detected
in the PBS-challenged group. The amount of BAG in
sera ranged from 0.027 μg/ml to 5.173 μg/ml, with an
average of 0.849 μg/ml (Figure 7A).
Next, to determine the influence of BAG on LT-
induced lethality in vivo, 6-week-old mice were given a
tail vein injection of 20 μg BAG alone or with LT. Mice
were then monitored for 14 days. All mice (100%; 8/8)
that received PBS or 20 μg BAG alone survived, but
only 50% (6/12) of the mice that received LT survived
(Figure 7B). Survival rates of mice that received BAG
with LT decreased significantly to 8% (1/13; P = 0.0016)
as compared with those given LT alone (6/12). To verify
whether the increase of mice lethality was due to the
Figure 5 BAG and B. anthracis spores induce NF-κB activation. (A) RAW264.7 cells were cotransfected for 24 h with a firefly luciferase
reporter plasmid regulated by the NF-κB transcription factor together with pRL-TK Renilla luciferase plasmid as an internal control for transfection
efficiency. Then, the cells were stimulated with the indicated concentrations of BAG for a further 8 h. At the end of the stimulation period, the
cells were lysed, and the dual luciferase activities were measured. Firefly luciferase activity was normalized to Renilla luciferase activity. Values are
the mean ± SD of triplicate assays. *P <0.05 as compared with the untreated control group. (B) RAW264.7 cells were not stimulated or were
stimulated with 1 μg/ml BAG or LPS or with B. anthracis spores (MOI of 10) for 1 h and then stained with anti-p65 followed by Alexa-488–conjugated
secondary antibody and DAPI. Confocal images were obtained.
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inhibiting monoclonal antibody) was administered into
each mouse before injecting BAG with LT. Conse-
quently, the decreased survival due to the injection ofBAG with LT was significantly recovered up to 75%
(6/8) by injection of Infliximab (P = 0.0061) compared to
BAG + LT group. All mice (100%; 8/8) that received
Infliximab alone were alive. These results suggest that
Figure 6 Treatment with BAG and pretreatment with TNF-α
enhance LT-mediated cytotoxicity in a concentration-dependent
manner. (A) J774A.1 cells were treated with medium alone, LT
(0.5 μg/ml PA + 0.05 μg/ml LF), or LT + 0, 0.1, 1, or 10 μg/ml BAG.
(B) J774A.1 cells were pre-treated with 0, 0.25, 0.5, or 1 μg/ml TNF-α
for 24 h, and then LT (0.5 μg/ml PA +0.05 μg/ml LF) was added.
After the 4-h incubation with LT, cell viability was determined using
the MTT assay. The y axis represents the percent survival relative to
control values and is given as the mean ± SD derived from three
separate experiments. *P <0.05 as compared with the untreated
control group.
Figure 7 BAG was detected during spore infection and
enhanced LT-mediated lethality in mice. (A) Six-week-old BALB/c
female mice were infected with 5× LD50 of B. anthracis H9401 spores
(n = 16) or injected with PBS (n = 10) into the tail vein. After 24 h,
sera were isolated and filtered to remove bacilli. Genomic DNA was
quantified by analyzing the signal intensity of B. anthracis 16S rRNA
gene-specific PCR products. The relative amount was calculated based
on a standard curve equation. Each triangle or circle represents a single
experiment, and the horizontal bar indicates the mean. *P <0.05 as
compared with the PBS-injected group. (B) Kaplan-Meier survival
curves for BALB/c female mice injected with BAG and/or LT into the
tail vein. Infliximab (1 mg) was given by intraperitoneal route before
injection with LT + BAG. The percent survival was determined at 14 days
after injection. Mice injected with BAG (20 μg) with LT (PA 50 μg + LF
20 μg) showed decreased survival (open diamond) when compared
with LT (PA 50 μg + LF 20 μg) group (closed triangle), however, the
lowered survival was recovered by injecting TNF-α inhibiting Infliximab
(open circle). PBS (closed circle), BAG (20 μg, cross), and Infliximab
(1 mg, open rectangle) were injected as controls. *P <0.05 as compared
with the LT-BAG group.
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http://www.biomedcentral.com/1471-2180/14/300BAG produced in blood of infected mice during anthrax
progress can enhance the LT-induced death by increa-
sing TNF-α production.
Discussion
Innate immune responses induced by B. anthracis spore
infection are mediated by various types of PRR in-
cluding TLRs and NOD-like receptors [22-24]. In the
present study, we showed that infection by fully virulent
B. anthracis spores induced not only transcriptional up-
regulation of tlr9 but also production of TNF-α in
murine macrophage RAW264.7 cells. We showed that
TLR9 is involved in spore-induced TNF-α production by
pretreatment of RAW264.7 cells with both the endoso-
mal acidification inhibitor CQ and the TLR9 inhibitorODN2088. Purified BAG, a putative TLR9 ligand contai-
ning CpG motifs, led to production of TNF-α in a dose-
dependent manner in both RAW264.7 cells and BMDM,
and this production was mediated by MAPK and NF-кB
signaling pathways via TLR9. LT-mediated macrophage
cytotoxicity was enhanced by treatment with BAG and ex-
ogenous TNF-α. This effect was confirmed in vivo using
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BAG that had no lethal effect, co-injection of BAG with
LT increased LT-mediated lethality in mice and this effect
was significantly reversed by administration of Infliximab,
an anti-TNF-α monoclonal antibody. In addition, detec-
tion of BAG in the sera of anthrax spore–infected mice is
consistent with a possible role for BAG-induced TNF-α in
the lethality in mice. Based on these observations, we
postulated that BAG and other virulence factors during
anthrax infection are recognized by TLR9 and their corre-
sponding receptors, which induce TNF-α production via
MAPK and NF-кB signaling pathways. TNF-α induced by
BAG and other virulence factors enhances LT-mediated
cytotoxicity, which results in enhanced lethality in mice
(Figure 8).
We demonstrated that DNA from B. anthracis elicited
an inflammatory response by inducing production of the
proinflammatory cytokine TNF-α in mouse macrophages.
In line with our results, an immunostimulating effect of
bacterial DNA has been reported, although the sti-
mulatory potential differs among different species [25].
Genomic DNA from periodontopathogenic bacteria such
as Aggregatibacter actinomycetemcomitans and Porphy-
romonas gingivalis stimulates macrophages to produceFigure 8 Anthrax infection and BAG exposure enhances
LT-mediated cytotoxicity in macrophages via TNF-α production
and eventually increases lethality in mice. BAG during anthrax
infection is recognized by TLR9, which is inhibited by CQ or ODN2088
and induces TNF-α production via MAPK (inhibition target of U0126,
SB203580, and SP600125) and NF-κB pathways. Secreted TNF-α by BAG
and other virulence factors of B. anthracis enhances LT-mediated
macrophage death and eventually increases the lethality of mice.TNF-α and IL-6 [26]. DNA from group B streptococcus,
which causes neonatal sepsis and meningitis, also activates
macrophages to produce TNF-α [27]. In addition, DNA
from Gram-negative E. coli and Gram-positive bacteria
such as Enterococcus faecalis and Staphylococcus aureus
triggers macrophages to release TNF-α [15]. In contrast,
probiotic Lactobacillus plantarum genomic DNA does
not elicit TNF-α production in the human macrophage
cell line THP-1 [28]. Bacterial genomic DNA has been
considered one of the principal contributors to sepsis [15].
TLR9-deficient mice are resistant to polymicrobial sepsis
in an experimental peritonitis model [29]. Intravenous
administration of 300 μg genomic DNA from E. coli to
DBA/2 mice does not induce lethality, whereas 75% of
mice die when given the same amount of E. coli DNA plus
100 μg LPS [30]. Additionally, D-galactosamine–sensitized
mice, which are an in vivo model for sepsis, die because of
macrophage-derived TNF-α, which is induced by 300 μg
E. coli DNA or injection of 10 nmol ODN1668, a synthetic
TLR9 ligand [15]. In our study, administration of 20 μg
BAG alone did not alter survival rates in mice, whereas
BAG with LT augmented the death of mice as compared
with LT treatment alone. These results indicate that BAG
can induce anthrax pathogenesis with other components
such as LT, although BAG alone is not sufficient to induce
lethality in mice.
LT is a major virulence factor for anthrax pathogenesis
[1], and it is believed to be responsible for causing the
death of infected organisms [31]. Moreover, LT induces
the death of macrophages derived from certain inbred
rodent strains via activation of caspase-1 and nucleotide
binding domain and leucine-rich repeat containing protein
1b (NALP1b) [32]. NALP1, a member of the NOD-like
receptors family, directly binds to apoptosis-associated
speck-like protein containing a CARD (ASC) and caspase-
1 through its pyrin domain and caspase recruitment
domain, respectively, to form an inflammasome, which
results in macrophage death. The Nalp1 locus in mice
possesses three paralogs, Nalp1a, Nalp1b, and Nalp1c
[33]. Nalp1b is highly polymorphic in rodent strains and
has been reported to determine macrophage sensitivity
to LT [32]. LT rapidly induces capase-1–dependent
pyroptosis in macrophages carrying the LT-sensitive
allele of Nalp1b (Nalp1bs), whereas LT slowly induces
caspase-1–independent apoptosis in LT-resistant macro-
phages (Nalp1bR) through cleavage of MEKs [32]. How-
ever, multiple reports have documented inconsistent
LT-mediated macrophage death [14,16,31]. Indeed, LT
induces apoptosis of activated macrophages with the LT-
sensitive allele of Nalp1b (e.g., J774A.1 cells or bone
marrow–derived macrophages from BALB/c mice) by
inhibiting p38 kinase but not through caspase-1 activation
[31]. Additionally, TNF-α produced by bacterial compo-
nents promotes LT-mediated cell death in LT-resistant
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Conversely, TNF-α is involved in LT-mediated cell death
in LT-sensitive bovine macrophages [16]. In agreement
with this previous report, we observed greater cell death
by LT and BAG than by LT alone in LT-sensitive macro-
phages and mice.
The inflammatory response is beneficial to the host, as
it helps the host eliminate pathogens. However, excessive
immune responses can be deleterious to the host because
they can result in tissue damage or organ dysfunction in-
cluding sepsis [34]. TNF-α is a pleiotropic cytokine that
not only is involved in the growth, differentiation, and cell
death of many cell types but also is implicated in patho-
physiological conditions including rheumatoid arthritis,
inflammatory bowel disease, atherosclerosis, and viral he-
patitis [35]. TNF-α is a key mediator of septic shock syn-
drome and apoptosis of macrophages induced by bacterial
endotoxin [36]. Treatment with TNF-α is sufficient to in-
duce death in various cell types including hepatocytes,
preadipocytes, and fibroblasts [37]. TNF-α is also crucially
involved in macrophage death mediated by B. anthracis
LT alone or LT together with PGN, PGA, or LPS [14]. In-
deed, a sublytic dose of LT alone induces TNF-α secretion
in macrophages, and pretreatment with a TNF-α–neutral-
izing antibody attenuates LT-induced macrophage death
[16]. In addition, LT in combination with bacterial compo-
nents such as LPS, PGN, and PGA promotes LT-mediated
macrophage death, which is attenuated by pretreatment
with a TNF-α–neutralizing antibody [14]. As those pre-
vious reports, administration of an anti-TNF-α mo-
noclonal antibody, Inflximab, significantly reversed the
BAG + LT-mediated lethality of mice in our study.
Recently, a number of studies have shown that LT
could cause increase of vascular permeability and follo-
wing vascular leakage, thereby contributing to shock and
death of animals [38-41]. Bacterial constituents such as
LPS and bacterial DNA have been known to induce
increase of vascular permeability and leakage [42,43]. In
addition, TNF-α could also induce the vascular leakage
[44] and inhibitor of TNF-α reduced LPS-induced vas-
cular leakage [43]. During anthrax infection, B. anthracis
has been known to reach 107-108 organisms per milli-
liter of blood and induce high amount of cytokines such
as TNF-α, IL-6, and IL-1β in primary macrophages and
an experimental animal model [10,45]. Thus, BAG-
induced TNF-α production by immune cells such as
macrophages might enhance vascular leakage and septic
shock, thereby contributing to lethality of an infected or-
ganism. TNF-α produced by other bacterial components
described above would contribute to septic shock of an
infected animal through various mechanisms.
Our results showed that BAG led to significant in-
crease in TNF-α secretion. Therefore, TNF-α that is pro-
duced as a result of the presence of both BAG and LTmay enhance LT-mediated macrophage death. In the case
of B. anthracis, TNF-α may also be involved in spore-
induced sepsis in anthrax pathogenesis. Delayed death
was observed in B. anthracis spore–infected mice after
treatment with a TNF-α antibody [46]. In our study, at
24 h post-infection with B. anthracis spores, the amount
of BAG circulating in the blood was <0.89 μg/ml, but it
may increase as anthrax infection develops in mice, re-
sulting in TNF-α production. In our study, the maximal
concentration of BAG in in vitro culture supernatants
reached to 2.5 μg/ml when bacterial density was 8.1 ×
105 cfu/ml (data not shown). During anthrax infection in
animal models, it was reported that the concentration of
B. anthracis in blood may rise up to 107-108 cfu/ml [47].
Based on these observations including us, it is possible
that the concentration of BAG in the blood of infected
animal in the late phase of infection would be high
enough to induce TNF-α. Additionally, it has been re-
ported that some components of B. anthracis such as
PGN, anthrolysin O, and PGA induced considerable
amount of TNF-α in host immune cells [12,13,24]. There-
fore, TNF-α secretion by BAG as well as by other compo-
nents of B. anthracis could contribute to pathogenesis of
anthrax. Therefore, we propose that the presence of BAG
circulating in the blood may enhance the toxic effects of
LT by increasing the TNF-α level.
Conclusions
The current study demonstrates that BAG during an-
thrax infection is recognized by TLR9 and this recogni-
tion stimulates TNF-α production via MAPK and NF-κB
pathways in mouse macrophages. During infection, se-
creted TNF-α due to BAG-mediated TLR9 activation as
well as activation by other components of B. anthracis
might enhance LT-mediated macrophage cytotoxicity
and eventually increases the lethality of mice.
Methods
Reagents and chemicals
CpG ODN2395, TLR9 inhibitors ODN2088, and CQ were
purchased from InvivoGen (San Diego, CA, USA). Recom-
binant TNF-α was purchased from Abcam (Cambridge,
UK). All MAPK inhibitors were purchased from Calbiochem
(Darmstadt, Germany). MAPK antibodies against ERK,
phospho-ERK (p-ERK), p38, phospho-p38 (p-p38), JNK,
and phospho-JNK (p-JNK) were from Cell Signaling
Technology (Beverly, MA, USA). Dulbecco’s modified
Eagle’s medium (DMEM), RPMI-1640, fetal bovine serum
(FBS), and antibiotics for cell culture were purchased from
Invitrogen (Carlsbad, CA, USA).
Cell culture
The mouse macrophage cell lines RAW264.7 (TIB-71)
and J774A.1 (TIB-67) were obtained from the American
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The cells were cultured in DMEM supplemented with
10% FBS, 100 U/ml penicillin, and 100 μg/ml strepto-
mycin at 37°C in a humidified incubator with 5% CO2.
BMDMs were prepared as described previously [48]. In
brief, bone marrow cells were isolated from six-week old
TLR 9 wild-type (WT) (C57BL/6, Orient Bio Inc., Seoul,
Korea) and TLR9 knock-out (KO) female mice which
were kindly provided by professor Seong Kug Eo at
Chonbuk National University by flushing marrow space
of tibiae and femurs with a syringe filled with RPMI
1640. To differentiate bone marrow cells into BMDMs,
the cells were then cultured in aforementioned complete
DMEM with 50 μM β-mercaptoethanol in the presence
of 30% L929 conditioned media as a source of M-CSF
for 6–8 days at 37°C in a humidified incubator with 5%
CO2. BMDM were trypsinized and seeded at 24 well
plates for experiments.
Spore preparation and infection
Encapsulated toxigenic B. anthracis ATCC 14578 (pXO1+
pXO2+) or B. anthracis H9401 (pXO1+ pXO2+) was
streaked and incubated on blood agar plates overnight at
37°C. Spores were prepared as described [49] and stored
at 4°C.
For spore infection experiments, RAW264.7 cells
(1 × 105 cells/ml) were seeded onto a 24-well plate in
complete DMEM without antibiotics and grown overnight.
The cells were washed twice with serum-free DMEM and
then infected with the indicated MOI of B. anthracis
ATCC 14578 spores for 45 min. Unphagocytosed spores
were removed by washing with complete DMEM five
times, and the cells were further cultured for the indicated
times.
Bacterial culture and genomic DNA preparation
B. anthracis ATCC 14578 genomic DNA was isolated
from bacteria that were cultured on brain heart infusion
plates. BAG was prepared as described [25] and stored at
−20°C. To eliminate endotoxin contamination, samples
were further purified using Triton X-114 as described
[50]. Endotoxin levels were measured in endotoxin units
per milliliter (EU/ml) using a Limulus amebocyte lysate
assay kit (Lonza, Walkersville, MN, USA). According to
this assay, 10 μg/ml DNA contained <0.1 EU/ml.
ODN2088 and CQ treatment upon spore infection and
BAG stimulation
To determine whether TLR9 is involved in TNF-α pro-
duction by B. anthracis ATCC 14578 spores, RAW264.7
cells were pretreated with 0, 2.5, 5, or 10 μM ODN2088
for 1 h, followed by infection with B. anthracis spores
(MOI of 10) for 5 h. Then, culture supernatants were
harvested by centrifugation at 12,000 × g for 10 min.To investigate whether BAG-induced TNF-α produc-
tion was also mediated by TLR9, RAW264.7 cells were
pretreated with 0, 1, 10, or 100 nM ODN2088 or 0, 0.1,
1, or 10 μΜ CQ, followed by stimulation with 10 μg/ml
BAG for an additional 24 h. Secreted TNF-α was mea-
sured using an ELISA kit (BioLegend, San Diego, CA,
USA).
Real-time RT-PCR
RAW 264.7 cells (3 × 105 cells/ml) were plated in
a 6-well plate, cultured overnight, and stimulated
with various concentrations of BAG for the indicated
times. Total RNA was isolated from RAW264.7 cells
with TRIzol reagent (Invitrogen) according to the ma-
nufacturer’s instructions. cDNA was synthesized from
5 μg total RNA using random hexamers and re-
verse transcriptase (Promega, Madison, WI, USA).
Real-time semi-quantitative PCR was conducted using
the ABI Prism® Sequence Detection System 7500 (Applied
Biosystems, Foster City, CA, USA) and Power SYBR®
Green PCR Master Mix (Applied Biosystems) under the
following conditions: denaturation at 95°C for 1 min and
amplification by cycling 40 times at 95°C for 15 s, 60°C for
15 s, and 72°C for 34 s. To determine TLR9 and TNF-α
mRNA levels, the copy number for each was normalized
to that of ribosomal protein L19 (L19) using the 2−ΔΔCt
method, and then the value was compared to that of the
untreated control group. The PCR primer sequences
included TLR9 forward primer, 5′-ACTTCGTCCAC
CTGTCCAAC-3′, and reverse primer, 5′-TCATGTGG
CAAGAGAAGTGC-3′; TNF-α forward primer, 5′-TC
CCAGGTTCTCTTCAAGGGA-3′, and reverse primer,
5′-GGTGAGGAGCACGTAGTCGG-3′; L19 forward
primer, 5′-CCAAGAAGATTGACCGCCATA-3′, and re-
verse primer, 5′-CAGCTTGTGGATGTGCTCCAT-3′.
Real-time RT-PCR was performed in triplicate for each
RNA sample. The mean ± SD of the relative TLR9 and
TNF-α copy number was expressed as the fold induction
and was compared with that of the untreated control
group.
Transfection with small interfering RNA (siRNA)
The siRNA that targets mouse TLR9 (ON-TARGET
plus SMART-pool, L-040659-01-0005) and the non-
targeting siRNA (D-001810-01-05) were purchased from
Dharmacon (Lafayette, CO, USA). In brief, RAW264.7 cells
(5 × 104 cells/ml) were plated in a 96-well plate for 16 h
and then transiently transfected with 200 nM TLR9 siRNA
or control siRNA using Oligofectamine (Invitrogen)
according to the manufacturer’s instructions. Four hours
after transfection, the medium was replaced with complete
DMEM containing 10% heat-inactivated FBS, 100 U/ml
penicillin, and 100 μg/ml streptomycin. After 36 h, cells
were stimulated with 10 μg/ml BAG or 1 μM CpG2395 for
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lected for TNF-α analysis with ELISA.
Western blot analysis
RAW264.7 cells were stimulated with 10 μg/ml BAG for
0, 15, 30, or 60 min. Then, the cells were lysed with NP40
Cell Lysis Buffer (Invitrogen) on ice for 30 min. The cell
lysates were collected by centrifugation at 13,000 × g for
10 min, and a 30 μg sample of total protein was separated
by 10% SDS-PAGE and electro-transferred onto a polyvi-
nylidene fluoride membrane. The membrane was blocked
with 5% skim milk in TBS (50 mM Tris–HCl, 150 mM
NaCl, pH 7.6) at room temperature for 1 h and then
incubated with rabbit anti-MAPK (1:1000) at 4°C over-
night. After washing three times with TBST (TBS with
0.5% Tween 20), the membrane was incubated with
HRP-conjugated goat anti–rabbit IgG secondary antibody
(1:3000) in blocking buffer at room temperature for 1 h.
Next, the membrane was washed three times with TBST,
and the immunoreactive bands were detected with ECL
Western blotting reagents (Invitrogen) and X-ray film
(Eastman Kodak, Rochester, NY, USA).
TNF-α ELISA
RAW264.7 cells were plated at 5 × 105 cells/ml in 96-well
plates and cultured overnight in the above medium. For
experiments using various inhibitors, the cells were pre-
incubated with the inhibitor for 1 h, followed by stimula-
tion with BAG for an additional 24 h. BMDM were plated
at 1 × 106 cells/ml in 24-well plates followed by stimula-
tion with BAG (0, 0.1, 1, or 10 μg/ml), CpG2395 (1 μM),
or PAM3CSK4 (1 μg/ml) for 24 h. At the end of the
incubation period, the culture medium was collected, and
the TNF-α level was analyzed using an ELISA kit
(BioLegend).
Reporter gene assay
RAW 264.7 cells (5 × 105 cells/ml) were plated in 12-well
plates. The cells were transfected with 1 μg pNF-κB-Luc
(Clontech, Palo Alto, CA, USA) together with 0.1 μg pRL-
TK Renilla luciferase plasmid (Promega) using LipofectA-
MINE and PLUS reagent (Invitrogen) according to the
manufacturer’s instructions. Twenty-four hours after
transfection, cells were stimulated with 0, 0.1, or 10 μg/ml
BAG for a further 8 h. Cells were then lysed with reporter
lysis buffer (Promega), and cell lysates were assayed for
firefly and Renilla luciferase activity with the Dual Lu-
ciferase Reporter Assay System (Promega) in a Victor
1420 Multilabel counter (PerkinElmer Life and Analytical
Sciences, Waltham, MA, USA).
Immunofluorescence microscopy
RAW264.7 cells (1 × 105/ml) were seeded on a chamber
slide (Nalge Nunc, Rochester, NY, USA) and then treatedwith 1 μg/ml BAG and 1 μg/ml LPS for 1 h or with B.
anthracis ATCC 14578 spores (MOI of 30) for 45 min at
37°C. After incubation for the indicated times, the cells
were washed with cold PBS (GenDEPOT, Barker, TX,
USA) and fixed with cold methanol for 10 min. Samples
were subsequently blocked with 15% goat serum for 1 h
at room temperature and washed with PBST (PBS with
0.5% Tween 20). Cells were stained with anti-NF-κB p65
primary antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA; 1:50) for 2 h at room temperature. Cells
were then stained with Alexa Fluor 488–conjugated
anti-mouse secondary antibody (Invitrogen; 1:100) for
1 h at room temperature and washed three times with
PBST. Nuclei were stained with DAPI (Invitrogen). After
being washed with PBST, samples were mounted and
analyzed using an Olympus FV1000 confocal microscope
(Tokyo, Japan).
Determination of the effect of BAG and TNF-α on
LT-mediated cytotoxicity
To evaluate the effect of BAG and TNF-α on LT cyto-
toxicity, we performed LT-mediated cytotoxicity experi-
ments with J774A.1 cells. Monolayers of J774A.1 cells in
DMEM containing 10% FBS were cultured at 37°C in
96-well plates (SPL Plastic Labware, Pochon, Korea) at
1.5 × 105 cells/well. BAG was diluted with serum-free
DMEM and added to the cells in the 96-well plate at
final concentrations of 0 (medium alone), 0.1, 1, and
10 μg/ml. PA and LF were added to the cells at final
concentrations of 0.5 μg/ml and 0.05 μg/ml, respectively.
The mixtures were incubated for 1 h at 37°C before they
were added to J774A.1 cells. Then, the medium was re-
moved from the J774A.1 cell monolayers, and 100 μl of
the BAG/PA/LF mixture was added to the cells for 4 h.
To examine the effect of TNF-α on LT-mediated cyto-
toxicity, the cells were pretreated with 0, 250, 500, or
1000 ng/ml TNF-α for 24 h, followed by treatment with
PA and LF at final concentrations of 0.5 μg/ml and
0.05 μg/ml, respectively. After a 4-h incubation at 37°C
in 5% CO2, 100 μl MTT (Sigma-Aldrich, St. Louis, MO,
USA) was added to each well at a final concentration of
0.5 mg/ml. After additional incubation at 37°C for 1 h,
the J774A.1 cells were lysed by adding 100 μl extraction
buffer (90% isopropyl alcohol containing 25 mM HCl
and 0.5% [w/v] SDS). Absorbance was then measured at
570 nm with an ELISA reader (Tecan, Männedorf,
Switzerland). For each assay, controls consisted of six
wells with LT only and six wells with culture medium
only. Each sample was tested in duplicate and averaged
for analysis.
Quantification of BAG after infection
All animal studies were performed under the approval of
the Institutional Animal Care and Use Committee of the
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BALB/c female mice (Orient Bio Inc.) were housed in a
specific pathogen-free environment and six-week-old
mice were infected with 5× LD50 of B. anthracis H9401
spores or PBS as a control by tail vein injection. After
24 h, mice were sacrificed, and sera were isolated. For
removal of bacilli, sera were filtered through 0.2-μm
sterile syringe filters. Genomic DNA was isolated from
sera using DNeasy Blood and Tissue Kit (QIAGEN),
and PCR was performed using B. anthracis 16S rRNA
gene–specific primers (forward, 5′-AGAGTTTGATCC
TGGCTCAG-3′; reverse, 5′-AGAAAGGAGGTGATC
CAGCC-3′). Serially diluted DNA (1.56 pg-5 μg) iso-
lated from B. anthracis 14578 was spiked into the nor-
mal mouse blood as a standard and DNA purification
procedures were performed as described above inclu-
ding standards. Isolated genomic DNA was used as a
template, and PCR conditions were as follows: 95°C for
2 min; 30 cycles of 95°C for 30 s, 60°C for 40 s, and 72°C
for 60 s; 72°C for 10 min. PCR products were separated
on 1.2% agarose gels, and the signal intensity of spe-
cific bands was quantified using densitometry software
(Alpha Innotech, San Jose, CA, USA). The standard
curve equation was derived by analyzing signal inten-
sities of the PCR products using known quantities of
B. anthracis genomic DNA. Final DNA quantities were
calculated by interpolating the signal intensity of the
tested samples. Sequences of specific PCR-amplified
bands were confirmed by sequencing.In vivo challenge with LT, BAG and TNF-α inhibitor
Five-week-old BALB/c female mice were housed in a
specific pathogen-free environment (Orient Bio, Korea)
and six-week-old mice were injected with LT (PA
50 μg + LF 20 μg) and/or 20 μg BAG by tail vein injec-
tion (n = 8-13 mice per treatment). To block the effect
of BAG-induced TNF-α, Infliximab (Remicade®, Janssen
Biotech Inc., Horsham, PA, USA) was used. Before in-
jection of LT + BAG, 1 mg of Infliximab was injected
into each mouse via intraperitoneal route. Mice were
then monitored for survival for 14 days.Statistical analysis
Differences in survival between groups of mice were
determined using the log-rank test with GraphPad
Prism 4.0 software (GraphPad Software, Inc., San
Diego, CA, USA). For other measures, the mean
values ± SD were determined for each treatment group
in the individual experiment. Treatment groups were
compared with the appropriate control, and statistical
significance was calculated with the two-tailed Student’s
t-test. Differences were considered significant when the
P value was <0.05.Additional file
Additional file 1: Figure S1. Pretreatment of low concentrations of TNF-a
and BAG enhances LT-mediated cytotoxicity. (A) J774A.1 cells were pre-treated
with 0, 7.8, 15.6, or 31.2 ng/ml TNF-a for 24 h, and then LT (0.1 μg/ml PA +
0.1 μg/ml LF) was added. (B) J774A. 1 cells were pre-treated with 0, 0.1, 1,
or 10 μg/ml BAG for 24 h, and then LT (0.1 μg/ml PA + 0.1 μg/ml LF) was
added. After the 4-h incubation with LT, cell viability was determined using
MTT assay. The y axis represents the percent survival relative to control
values and is given as the mean ± SD derived from three separate
experiments. *P < 0.05 as compared with the untreated control group.
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